NCT00199082View on ClinicalTrials.gov

Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults

PHASE4CompletedINTERVENTIONAL
Enrollment

650

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Burkitt's LymphomaBurkitt's LeukemiaMediastinal NeoplasmsLymphoblastic LymphomaLarge Cell Anaplastic Lymphoma
Interventions
DRUG

Adriamycin

DRUG

Cyclophosphamide

DRUG

Cytarabine

DRUG

Dexamethasone/Prednisolone

DRUG

VP16

DRUG

Ifosfamide

DRUG

Methotrexate

DRUG

G-CSF

DRUG

Rituximab

DRUG

Vincristine/Vindesine

PROCEDURE

Irradiation (in specific conditions)

Trial Locations (1)

60590

University Hospital, Medical Dept. II, Frankfurt

All Listed Sponsors
lead

Nicola Goekbuget

OTHER

NCT00199082 - Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults | Biotech Hunter | Biotech Hunter